RAPP
Rapport Therapeutics, Inc.
27.02
+1.06 (+4.08%)
52w low 22.06
52.93 high
16.1% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 31.16M | 70.17M | 56.80M | 52.65M | |
| Current Assets | 31.27M | 150.87M | 309.80M | 498.56M | |
| Net PP&E | 335.00K | 4.00M | 4.97M | 12.88M | |
| Total Assets | 31.60M | 155.42M | 314.93M | 512.43M | |
| Current Liabilities | 1.66M | 8.80M | 8.77M | 19.05M | |
| Total Debt | 0.00 | 2.15M | 1.48M | 11.48M | |
| Total Liabilities | 41.66M | 181.06M | 9.51M | 27.78M | |
| Retained Earnings | -10.65M | -45.44M | -123.75M | -235.23M | |
| Shareholders Equity | -10.06M | -25.63M | 305.43M | 484.65M | |
| Working Capital | 29.61M | 142.07M | 301.04M | 479.51M | |
| Shares Outstanding | 35.38M | 35.38M | 36.58M | 47.77M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--